Belpointe Asset Management LLC Becton Dickinson & CO Transaction History

Belpointe Asset Management LLC

  • $1.51 Billion
  • Q4 2024

A detailed history of Belpointe Asset Management LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Belpointe Asset Management LLC holds 2,319 shares of BDX stock, worth $527,711. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,319
Previous 2,329 0.43%
Holding current value
$527,711
Previous $561,000 6.24%
% of portfolio
0.03%
Previous 0.04%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$220.02 - $243.75 $2,200 - $2,437
-10 Reduced 0.43%
2,319 $526,000
Q3 2024

Nov 12, 2024
BUY
$221.47 - $242.41 $51,381 - $56,239
232 Added 11.06%
2,329 $561,000
Q2 2024

Aug 02, 2024
BUY
$225.07 - $246.17 $49,290 - $53,911
219 Added 11.66%
2,097 $490,000
Q1 2024

May 08, 2024
SELL
$233.45 - $247.73 $4,902 - $5,202
-21 Reduced 1.11%
1,878 $464,000
Q4 2023

Feb 13, 2024
SELL
$232.24 - $267.23 $20,901 - $24,050
-90 Reduced 4.52%
1,899 $463,000
Q3 2023

Nov 15, 2023
BUY
$254.9 - $283.59 $150,136 - $167,034
589 Added 42.07%
1,989 $514,000
Q2 2023

Aug 14, 2023
SELL
$238.39 - $265.32 $234,575 - $261,074
-984 Reduced 41.28%
1,400 $369,000
Q1 2023

May 15, 2023
BUY
$229.71 - $259.35 $19,984 - $22,563
87 Added 3.79%
2,384 $590,000
Q4 2022

Feb 08, 2023
SELL
$218.29 - $256.91 $82,513 - $97,111
-378 Reduced 14.13%
2,297 $584,000
Q3 2022

Nov 14, 2022
BUY
$51.03 - $264.23 $46,131 - $238,863
904 Added 51.04%
2,675 $596,000
Q2 2022

Aug 02, 2022
BUY
$234.74 - $275.42 $2,112 - $2,478
9 Added 0.51%
1,771 $437,000
Q1 2022

Apr 28, 2022
SELL
$243.64 - $270.48 $151,056 - $167,697
-620 Reduced 26.03%
1,762 $469,000
Q4 2021

Feb 15, 2022
BUY
$230.08 - $250.94 $217,425 - $237,138
945 Added 65.76%
2,382 $599,000
Q3 2021

Nov 15, 2021
SELL
$232.72 - $256.47 $105,654 - $116,437
-454 Reduced 24.01%
1,437 $354,000
Q2 2021

Aug 09, 2021
BUY
$232.65 - $254.58 $185,654 - $203,154
798 Added 73.01%
1,891 $460,000
Q1 2021

May 14, 2021
SELL
$232.09 - $256.88 $19,727 - $21,834
-85 Reduced 7.22%
1,093 $266,000
Q4 2020

Feb 16, 2021
BUY
$221.92 - $245.94 $221 - $245
1 Added 0.08%
1,178 $295,000
Q3 2020

Nov 13, 2020
BUY
$215.77 - $276.76 $14,025 - $17,989
65 Added 5.85%
1,177 $274,000
Q3 2020

Nov 13, 2020
SELL
$215.77 - $276.76 $3,883 - $4,981
-18 Reduced 1.59%
1,112 $256,000
Q2 2020

Jul 20, 2020
BUY
$219.9 - $263.41 $3,958 - $4,741
18 Added 1.62%
1,130 $271,000
Q1 2020

Jul 20, 2020
SELL
$195.69 - $279.01 $26,026 - $37,108
-133 Reduced 10.68%
1,112 $256,000
Q4 2019

Feb 18, 2020
BUY
$236.45 - $266.82 $108,767 - $122,737
460 Added 58.6%
1,245 $339,000
Q3 2019

Jan 16, 2020
SELL
$230.58 - $256.08 $922 - $1,024
-4 Reduced 0.51%
785 $199,000
Q2 2019

Nov 22, 2019
SELL
$217.4 - $246.08 $80,438 - $91,049
-370 Reduced 31.92%
789 $0
Q1 2019

Jun 11, 2019
BUY
$206.05 - $248.17 $92,928 - $111,924
451 Added 63.7%
1,159 $290,000
Q4 2018

Mar 06, 2019
SELL
$204.73 - $257.93 $76,773 - $96,723
-375 Reduced 34.63%
708 $160,000
Q3 2018

Nov 23, 2018
SELL
$233.07 - $256.0 $346,108 - $380,160
-1,485 Reduced 57.83%
1,083 $283,000
Q2 2018

Aug 06, 2018
BUY
$208.1 - $233.85 $534,400 - $600,526
2,568 New
2,568 $615,000
Q1 2018

Aug 06, 2018
SELL
$205.46 - $240.27 $237,717 - $277,992
-1,157 Closed
0 $0
Q4 2017

Feb 15, 2018
SELL
$189.0 - $222.64 $8,883 - $10,464
-47 Reduced 3.9%
1,157 $248,000
Q3 2017

Nov 16, 2017
BUY
$186.89 - $198.9 $225,015 - $239,475
1,204
1,204 $236,000

Others Institutions Holding BDX

# of Institutions
1,800
Shares Held
260M
Call Options Held
1.27M
Put Options Held
1.09M
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Belpointe Asset Management LLC Portfolio

Follow Belpointe Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email